ConductScience.org, home

Trial · NCT06319274

Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure

NCT06319274, Phase 2, Recruiting, Pär Johansson

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure. Trials, record NCT06319274. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06319274

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure
NCT number
NCT06319274
Status
Recruiting
Phases
Phase 2
Enrollment
450 participants, estimated
Lead sponsor
Pär Johansson
Conditions
Acute Respiratory Failure, Endothelial Dysfunction, Pulmonary Infection
Interventions
Iloprost, Isotonic saline
First posted
2024-03-20
Last updated
2025-08-22

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary28-day mortalityDay 28All-cause mortality at day 28
Secondary90-day mortalityDay 90All-cause mortality at day 90
SecondaryVasopressor-free daysUntil ICU discharge, maximun 90 days after randomization]Days alive without vasopressor in the ICU within 28- and 90 days
SecondaryRenal replacement-free daysUntil ICU discharge, maximun 90 days after randomization]Days alive without renal replacement in the ICU within 28- and 90 days
SecondaryMechanical ventilation free daysUntil ICU discharge, maximun 90 days after randomization]Days alive without mechanical ventilation in the ICU within 28- and 90 days
SecondarySerious adverse reactions (SARs)Until day 7 after randomizationTotal number and numbers of patient with one or more serious adverse reactions within the first 7 days
SecondarySerious adverse events (SAEs)Until day 7 after randomizationTotal numbers and numbers of patients with one or more serious adverse events within the first 7 days

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06319274

GET https://conductscience.org/api/trials/v1/NCT06319274/registered